Cargando…
Administration of 4-hexylresorcinol increases p53-mediated transcriptional activity in oral cancer cells with the p53 mutation
The p53 mutation is inherent in over 50% of human cancers. In head and neck squamous cell carcinoma, the p53 mutation is associated with a poor prognosis. 4-Hexylresorcinol (4HR) is a pharmacologic chaperone. The present study aimed to investigate the effect of 4HR on p53 transcriptional activity in...
Autores principales: | Kang, Yei-Jin, Yang, Won-Geun, Chae, Weon-Sik, Kim, Dae-Won, Kim, Seong-Gon, Rotaru, Horatiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350967/ https://www.ncbi.nlm.nih.gov/pubmed/35856441 http://dx.doi.org/10.3892/or.2022.8375 |
Ejemplares similares
-
4-Hexylresorcinol Treatment before Degumming Increases the β-Sheet Structure of Silk Sericin and BMP-2 Expression in RAW264.7 Cells
por: Lee, Ji Hae, et al.
Publicado: (2022) -
The effect of 4-hexylresorcinol on xenograft degradation in a rat calvarial defect model
por: Kang, Yei-Jin, et al.
Publicado: (2016) -
Effects of 4-hexylresorcinol administration on the submandibular glands in a growing rat model
por: Yoon, Joo-Hyung, et al.
Publicado: (2022) -
Effects of 4-Hexylresorcinol on Craniofacial Growth in Rats
por: Lee, In-Song, et al.
Publicado: (2021) -
Accelerated biodegradation of silk sutures through matrix metalloproteinase activation by incorporating 4-hexylresorcinol
por: Jo, You-Young, et al.
Publicado: (2017)